Research is being conducted on the therapeutic potential of targeting glycan-binding proteins, which are involved in various diseases. Studies have explored the role of glycosylation in diseases such as cancer, interstitial lung diseases, and diabetic wound healing, as well as its impact on the immune system. The findings suggest that glycobiology may provide opportunities for innovative therapeutic approaches and early detection methods for certain diseases.